J. Bertram and P. Janik, Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture, Cancer Letters, vol.11, issue.1, pp.63-73, 1980.
DOI : 10.1016/0304-3835(80)90130-5

B. Zetter, ANGIOGENESIS AND TUMOR METASTASIS, Annual Review of Medicine, vol.49, issue.1, pp.407-424, 1998.
DOI : 10.1146/annurev.med.49.1.407

E. Rofstad and T. Danielsen, Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis, British Journal of Cancer, vol.80, issue.11, pp.1697-1707, 1999.
DOI : 10.1038/sj.bjc.6690586

D. Strohmeyer, Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer, Anticancer Res, vol.19, pp.1557-1561, 1999.

J. Hasan, R. Byers, and G. Jayson, Intra-tumoural microvessel density in human solid tumours, British Journal of Cancer, vol.5, issue.10, pp.1566-1577, 2002.
DOI : 10.1038/sj.bjc.6600315

K. Boles, A. Schmieder, A. Koch, R. Carano, Y. Wu et al., MR angiogenesis imaging with Robo4- vs. ??V??3-targeted nanoparticles in a B16/F10 mouse melanoma model, The FASEB Journal, vol.24, issue.11, pp.4262-4270, 2010.
DOI : 10.1096/fj.10-157933

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066028

B. Felding-habermann, E. Fransvea, O. Toole-'te, L. Manzuk, B. Faha et al., Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells, Clinical and Experimental Metastasis, vol.19, issue.5, pp.427-436, 2002.
DOI : 10.1023/A:1016377114119

J. Desgrosellier, L. Barnes, D. Shields, M. Huang, S. Lau et al., An integrin ??v??3???c-Src oncogenic unit promotes anchorage-independence and tumor progression, Nature Medicine, vol.63, issue.10, pp.1163-1169, 2009.
DOI : 10.1038/nm.2009

H. Nelson, P. Ramsey, J. Donohue, and L. Wold, Cell Adhesion Molecule Expression within the Microvasculature of Human Colorectal Malignancies, Clinical Immunology and Immunopathology, vol.72, issue.1, pp.129-136, 1994.
DOI : 10.1006/clin.1994.1116

S. Fox, G. Turner, K. Gatter, and A. Harris, The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium, The Journal of Pathology, vol.61, issue.4, pp.369-376, 1995.
DOI : 10.1002/path.1711770407

S. Barthel, J. Gavino, L. Descheny, and C. Dimitroff, Targeting selectins and selectin ligands in inflammation and cancer, Expert Opinion on Therapeutic Targets, vol.95, issue.11, pp.1473-1491, 2007.
DOI : 10.1158/1078-0432.CCR-05-1131

E. Jubeli, L. Moine, J. Vergnaud-gauduchon, and G. Barratt, E-selectin as a target for drug delivery and molecular imaging, Journal of Controlled Release, vol.158, issue.2, pp.194-206, 2012.
DOI : 10.1016/j.jconrel.2011.09.084

D. Senger, C. Perruzzi, M. Streit, V. Koteliansky, A. De-fougerolles et al., The ??1??1 and ??2??1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis, The American Journal of Pathology, vol.160, issue.1, pp.195-204, 2002.
DOI : 10.1016/S0002-9440(10)64363-5

L. Reynolds, L. Wyder, J. Lively, D. Taverna, S. Robinson et al., Enhanced pathological angiogenesis in mice lacking ??3 integrin or ??3 and ??5 integrins, Nature Medicine, vol.8, issue.1, pp.27-34, 2002.
DOI : 10.1038/nm0102-27

G. Tucker, Inhibitors of integrins, Current Opinion in Pharmacology, vol.2, issue.4, pp.394-402, 2002.
DOI : 10.1016/S1471-4892(02)00175-3

R. Parkes and S. Hart, Adhesion molecules and gene transfer, Advanced Drug Delivery Reviews, vol.44, issue.2-3, pp.135-152, 2000.
DOI : 10.1016/S0169-409X(00)00091-0

I. Dmitriev, Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors, Gene Ther, vol.8, pp.969-976, 2001.

D. Spragg, D. Alford, R. Greferath, C. Larsen, K. Lee et al., Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system, Proceedings of the National Academy of Sciences, vol.94, issue.16, pp.8795-8800, 1997.
DOI : 10.1073/pnas.94.16.8795

J. Gutheil, T. Campbell, P. Pierce, J. Watkins, W. Huse et al., Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3, Clin Cancer Res, vol.6, pp.3056-3061, 2000.

C. Kumar, M. Malkowski, Z. Yin, E. Tanghetti, B. Yaremko et al., Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist, Cancer Res, vol.61, pp.2232-2238, 2001.

J. Desgrosellier and D. Cheresh, Integrins in cancer: biological implications and therapeutic opportunities, Nature Reviews Cancer, vol.13, issue.1, pp.9-22, 2010.
DOI : 10.1038/nrc2748

C. Mas-moruno, F. Rechenmacher, and H. Kessler, Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation, Anti-Cancer Agents in Medicinal Chemistry, vol.10, issue.10, 2010.
DOI : 10.2174/187152010794728639

Y. Ye and X. Chen, Integrin Targeting for Tumor Optical Imaging, Theranostics, vol.1, pp.102-126, 2011.
DOI : 10.7150/thno/v01p0102

Z. Liu, R. Tian, Y. Li, W. An, Y. Zhuge et al., Inhibition of Tumor Angiogenesis and Melanoma Growth by Targeting Vascular E-Selectin, Annals of Surgery, vol.254, issue.3, pp.450-456, 2011.
DOI : 10.1097/SLA.0b013e31822a72dc

F. Formelli, C. Rossi, R. Supino, and G. Parmiani, In vivo characterization of a doxorubicin resistant B16 melanoma cell line, British Journal of Cancer, vol.54, issue.2, pp.223-233, 1986.
DOI : 10.1038/bjc.1986.166

M. Bissery, C. Nguyen, E. Bisagni, P. Vrignaud, and F. Lavelle, Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice, Investigational New Drugs, vol.34, issue.Supplement 1, pp.263-277, 1993.
DOI : 10.1007/BF00874425

M. Bissery, D. Guenard, F. Gueritte-voegelein, and F. Lavelle, Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue, Cancer Res, vol.51, pp.4845-4852, 1991.

T. Corbett, W. Leopold, D. Dykes, B. Roberts, D. Griswold et al., Toxicity and anticancer activity of a new triazine antifolate, 1982.

W. Dewys, Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors, Cancer Res, vol.32, pp.374-379, 1972.

?. Colon and C. , undifferentiated Highly metastatic: >90 to lungs %

?. Colon and A. , mucinous, drug insensitive Moderately to highly metastatic: >80 to lungs and to lymph nodes %, pp.26-57